Workup and Management of Premenopausal Osteoporosis
Marriam Ali1, Pauline M Camacho1
1Department of Endocrinology, Osteoporosis and Metabolic Bone Disease Center, Loyola University Medical Center, 2160 South First Avenue, Maywood, IL 60153, USA.
Abstract:
The diagnosis and management of premenopausal low bone mass or osteoporosis is challenging as its relationship to low bone mass and risk of fracture is less defined. Premenopausal or perimenopausal women with low bone density or a history of fragility fractures should undergo a thorough evaluation of causes that predispose them to bone loss. Identification of these underlying risk factors such as estrogen deficiency or malabsorptive disorders offers a treatment strategy to reverse bone loss. This is a review of the diagnostic approach and subsequent management strategies of premenopausal low bone mass or osteoporosis.
Related Concept Videos
Menopause
Bone Remodeling
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Osteoclasts in Bone Remodeling
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...


